Menu
GWAS Study

Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis.

Vujkovic M, Keaton JM, Lynch JA et al.

32541925 PubMed ID
GWAS Study Type
1407282 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

VM
Vujkovic M
KJ
Keaton JM
LJ
Lynch JA
MD
Miller DR
ZJ
Zhou J
TC
Tcheandjieu C
HJ
Huffman JE
AT
Assimes TL
LK
Lorenz K
ZX
Zhu X
HA
Hilliard AT
JR
Judy RL
HJ
Huang J
LK
Lee KM
KD
Klarin D
PS
Pyarajan S
DJ
Danesh J
MO
Melander O
RA
Rasheed A
MN
Mallick NH
HS
Hameed S
QI
Qureshi IH
AM
Afzal MN
MU
Malik U
JA
Jalal A
AS
Abbas S
SX
Sheng X
GL
Gao L
KK
Kaestner KH
SK
Susztak K
SY
Sun YV
DS
DuVall SL
CK
Cho K
LJ
Lee JS
GJ
Gaziano JM
PL
Phillips LS
MJ
Meigs JB
RP
Reaven PD
WP
Wilson PW
ET
Edwards TL
RD
Rader DJ
DS
Damrauer SM
OC
O'Donnell CJ
TP
Tsao PS
CK
Chang KM
VB
Voight BF
SD
Saleheen D
Chapter II

Abstract

Summary of the research findings

We investigated type 2 diabetes (T2D) genetic susceptibility via multi-ancestry meta-analysis of 228,499 cases and 1,178,783 controls in the Million Veteran Program (MVP), DIAMANTE, Biobank Japan and other studies. We report 568 associations, including 286 autosomal, 7 X-chromosomal and 25 identified in ancestry-specific analyses that were previously unreported. Transcriptome-wide association analysis detected 3,568 T2D associations with genetically predicted gene expression in 687 novel genes; of these, 54 are known to interact with FDA-approved drugs. A polygenic risk score (PRS) was strongly associated with increased risk of T2D-related retinopathy and modestly associated with chronic kidney disease (CKD), peripheral artery disease (PAD) and neuropathy. We investigated the genetic etiology of T2D-related vascular outcomes in the MVP and observed statistical SNP-T2D interactions at 13 variants, including coronary heart disease (CHD), CKD, PAD and neuropathy. These findings may help to identify potential therapeutic targets for T2D and genomic pathways that link T2D to vascular outcomes.

148,726 European ancestry cases, 24,646 African American cases, 8,616 Hispanic cases, 46,511 Asian ancestry cases, 965,732 European ancestry controls, 31,446 African American controls, 11,829 Hispanic controls, 169,776 Asian ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1407282
Total Participants
GWAS
Study Type
No
Replicated
European, Hispanic or Latin American, East Asian, South Asian, African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.